Click here for a list of institutions participating in this trial
E4Z02 is looking at the potential value of taking l-carnitine as a supplement to combat cancer-related fatigue.
Patients participating in the study will be randomized to receive either l-carnitine or a placebo for four weeks, after which all participants will receive l-carnitine for an additional four weeks. Patients will be be evaluated for Quality of Life and fatigue symptoms at the beginning of the study, at the four week point and at the conclusion of the study.
You can learn more about treating cancer-related fatigue and anemia and about prostate cancer by visiting these web sites:
National Cancer Institute Information On Fatigue
American Cancer Society Information On Fatigue
Information about cancer clinical trials can be found at:
National Cancer Institute Clinical Trials Information
CancerTrials Help - Coalition of National cancer Cooperative Groups